Teneliximab
Teneliximab
Teneliximab (pronounced: ten-eh-lix-i-mab) is a monoclonal antibody designed for the treatment of various autoimmune diseases.
Etymology
The name "Teneliximab" is derived from the standard nomenclature for monoclonal antibodies. The suffix "-mab" indicates that it is a monoclonal antibody, while the prefix "Teneli-" does not have a specific meaning and is used for unique identification.
Usage
Teneliximab is used in the treatment of various autoimmune diseases. Autoimmune diseases are conditions in which the body's immune system mistakenly attacks its own cells. By using monoclonal antibodies like Teneliximab, it is possible to target specific cells or proteins and thus reduce the impact of these diseases.
Related Terms
- Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells. They are used in cancer treatment and autoimmune diseases.
- Autoimmune Disease: A condition in which your immune system mistakenly attacks your body. The immune system normally guards against germs like bacteria and viruses. When it senses these foreign invaders, it sends out an army of fighter cells to attack them.
- Immunotherapy: A type of cancer treatment that helps your immune system fight cancer. It is a type of biological therapy.
See Also
External links
- Medical encyclopedia article on Teneliximab
- Wikipedia's article - Teneliximab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski